Concepedia

Kelsey W. Nassar

KW

Statistics

Publications

4

Citations

244

H-Index

4

Active since

2018

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Moffitt Cancer Center

University of Colorado Denver

University of Colorado Cancer Center

Kelsey W. Nassar is an author at University of Colorado Anschutz Medical Campus specializing in oncology, molecular oncology, and targeted cancer therapy.

ORCID

Publications per year

2018–2021

4

Publications

4

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy

Carol M. Amato, Jennifer D. Hintzsche, Keith Wells et al. · Cancers · 2020 · 76 citations · Full text

, , +17

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd et al. · Cell Death and Disease · 2020 · 72 citations · Full text

, , +17

Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer

Thomas C. Beadnell, Kelsey W. Nassar, Madison M. Rose et al. · Oncogenesis · 2018 · 59 citations · Full text

, , +17

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

Kelsey W. Nassar, Jennifer D. Hintzsche, Stacey M. Bagby et al. · Molecular Cancer Therapeutics · 2021 · 37 citations · Full text

, , +17

1–4 of 4